KORU Medical Systems' Shareholders See 70% Return Over Three Years Despite Laggard Performance

KORU Medical Systems' investors have seen a 70% return over the last three years, but the company made a loss in the last 12 months. Revenue grew 10% annually over the last three years, but the annual gain of 19% is not impressive. The share price has a TSR loss of 1.0% per year over five years, but recent returns hint at a brighter future. The company's fundamentals, such as revenue and revenue growth, are key factors to consider.